Capital Research Global Investors’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $472M | Sell |
5,406,619
-6,630,079
| -55% | -$579M | 0.09% | 146 |
|
|
2025
Q1 | $822M | Sell |
12,036,698
-2,335,053
| -16% | -$159M | 0.18% | 110 |
|
|
2024
Q4 | $1.12B | Sell |
14,371,751
-3,576,503
| -20% | -$278M | 0.23% | 96 |
|
|
2024
Q3 | $1.2B | Buy |
17,948,254
+6,002,727
| +50% | +$402M | 0.25% | 89 |
|
|
2024
Q2 | $1.35B | Sell |
11,945,527
-1,490,365
| -11% | -$169M | 0.3% | 75 |
|
|
2024
Q1 | $1.86B | Sell |
13,435,892
-1,860,140
| -12% | -$258M | 0.42% | 56 |
|
|
2023
Q4 | $1.9B | Buy |
15,296,032
+2,695,296
| +21% | +$334M | 0.47% | 58 |
|
|
2023
Q3 | $1.18B | Buy |
12,600,736
+3,484,190
| +38% | +$325M | 0.32% | 77 |
|
|
2023
Q2 | $1.17B | Sell |
9,116,546
-158,069
| -2% | -$20.3M | 0.31% | 78 |
|
|
2023
Q1 | $1.08B | Sell |
9,274,615
-186,930
| -2% | -$21.7M | 0.31% | 81 |
|
|
2022
Q4 | $1.07B | Sell |
9,461,545
-1,068,693
| -10% | -$121M | 0.32% | 79 |
|
|
2022
Q3 | $848M | Buy |
10,530,238
+2,847,171
| +37% | +$229M | 0.28% | 90 |
|
|
2022
Q2 | $573M | Buy |
7,683,067
+5,040,557
| +191% | +$376M | 0.18% | 112 |
|
|
2022
Q1 | $1.35B | Buy |
2,642,510
+267,965
| +11% | +$137M | 0.33% | 75 |
|
|
2021
Q4 | $1.28B | Buy |
2,374,545
+844,916
| +55% | +$454M | 0.28% | 88 |
|
|
2021
Q3 | $836M | Buy |
1,529,629
+98,034
| +7% | +$53.6M | 0.2% | 113 |
|
|
2021
Q2 | $611M | Buy |
1,431,595
+1,036,207
| +262% | +$442M | 0.14% | 142 |
|
|
2021
Q1 | $142M | Buy |
+395,388
| New | +$142M | 0.03% | 273 |
|
|
2018
Q4 | – | Sell |
-360,000
| Closed | -$51.5M | – | 418 |
|
|
2018
Q3 | $51.5M | Buy |
+360,000
| New | +$51.5M | 0.02% | 332 |
|